2jh5
From Proteopedia
(Difference between revisions)
Line 12: | Line 12: | ||
===HUMAN THROMBIN HIRUGEN INHIBITOR COMPLEX.=== | ===HUMAN THROMBIN HIRUGEN INHIBITOR COMPLEX.=== | ||
+ | |||
+ | <!-- | ||
+ | The line below this paragraph, {{ABSTRACT_PUBMED_17336062}}, adds the Publication Abstract to the page | ||
+ | (as it appears on PubMed at http://www.pubmed.gov), where 17336062 is the PubMed ID number. | ||
+ | --> | ||
+ | {{ABSTRACT_PUBMED_17336062}} | ||
==About this Structure== | ==About this Structure== | ||
2JH5 is a 3 chains structure of sequences from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2JH5 OCA]. | 2JH5 is a 3 chains structure of sequences from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2JH5 OCA]. | ||
+ | |||
+ | ==Reference== | ||
+ | <ref group="xtra">PMID:17336062</ref><references group="xtra"/> | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: Thrombin]] | [[Category: Thrombin]] | ||
Line 42: | Line 51: | ||
[[Category: Zymogen]] | [[Category: Zymogen]] | ||
- | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun Mar 22 10:40:15 2009'' |
Revision as of 08:40, 22 March 2009
HUMAN THROMBIN HIRUGEN INHIBITOR COMPLEX.
Template:ABSTRACT PUBMED 17336062
About this Structure
2JH5 is a 3 chains structure of sequences from Homo sapiens. Full crystallographic information is available from OCA.
Reference
- Senger S, Chan C, Convery MA, Hubbard JA, Shah GP, Watson NS, Young RJ. Sulfonamide-related conformational effects and their importance in structure-based design. Bioorg Med Chem Lett. 2007 May 15;17(10):2931-4. Epub 2007 Feb 16. PMID:17336062 doi:http://dx.doi.org/10.1016/j.bmcl.2007.02.034
Page seeded by OCA on Sun Mar 22 10:40:15 2009
Categories: Homo sapiens | Thrombin | Chan, C. | Convery, M A. | Hubbard, J A. | Senger, S. | Shah, G P. | Watson, N S. | Young, R J. | Acute phase | Blood coagulation | Calcium | Disease mutation | Gamma-carboxyglutamic acid | Glycoprotein | Hydrolase | Inhibitor | Kringle | Polymorphism | Protease | Protease inhibitor | Serine protease | Serine protease inhibitor | Sulfation | Zymogen